Dr. Tracy has over 30 years of experience in Neuropsychological and Psychological Assessment. He is a Professor in the Departments of Neurology and Radiology, and he is the Director of Neuropsychological Division and the Director of the Cognitive Neuroscience and Brain Imaging Laboratory, both in the Department of Neurology at the Thomas Jefferson University/Jefferson Medical College.
He is one of our most trusted experts in these fields and has held a number of editorial positions within Journal Review Boards on the following topics: neuroimaging, human brain mapping. biological psychiatry, brain topography, epilepsia, schizophrenia and psychiatry.In addition to his hospital appointments, Dr. Tracy was certified by the American Board of Professional Psychology in Specialty Clinical Neuropsychology. He is a member of the following national societies: Cognitive Neuroscience Society, American Epilepsy Society, American Psychological Association, International Neuropsychological Society, Organization for Human Brain Mapping and Society Neuroscience; as well as a member of the  Philadelphia Neuropsychological Society.

Dr. Tracy is one of our top medical experts that we provide to our clients. He has decades of immeasurable experience in various subfields pertaining to neuropsychology. See below for the Abstract on a recent publication entitled, “Neuroimaging and connectomics of drug-resistant epilepsy at multiple scales: From focal lesions to macroscale networks” should you feel so inclined to parse the medical jargon!

“Epilepsy is among the most common chronic neurologic disorders, with 30%-40% of patients having seizures despite antiepileptic drug treatment. The advent of brain imaging and network analyses has greatly improved the understanding of this condition. In particular, developments in magnetic resonance imaging (MRI) have provided measures for the noninvasive characterization and detection of lesions causing epilepsy. MRI techniques can probe structural and functional connectivity, and network analyses have shaped our understanding of whole-brain anomalies associated with focal epilepsies. This review considers the progress made by neuroimaging and connectomics in the study of drug-resistant epilepsies due to focal substrates, particularly temporal lobe epilepsy related to mesiotemporal sclerosis and extratemporal lobe epilepsies associated with malformations of cortical development. In these disorders, there is evidence of widespread disturbances of structural and functional connectivity that may contribute to the clinical and cognitive prognosis of individual patients. It is hoped that studying the interplay between macroscale network anomalies and lesional profiles will improve our understanding of focal epilepsies and assist treatment choices. Wiley Periodicals, Inc. © 2019 International League Against Epilepsy”

And what in the world is “human brain mapping”? Our Dr. Tracy happens to be an expert in that too.

If you have the time, check out this research article he published in September 2012 on the topic as it relates specifically to epilepsy.